Drug‑Testing Industry and Pharmaceutical Firms Ask Federal Appeals Court to Block DEA’s Cannabis Rescheduling
The drug‑testing industry and several pharmaceutical companies have filed suit in a federal appeals court seeking to block the DEA’s plan to reclassify cannabis to Schedule III. They contend the rescheduling would damage their businesses, and legal battles over the reclassification are now intensifying.
For the full article, please visit the original source link below. CannabisInsight curates and summarizes key news from the global cannabis and hemp industry.
Source
marijuanamoment.net
This content is a summary and editorial by CannabisInsight based on the above source. Copyright of the original article belongs to the respective publisher.
Original Link
https://www.marijuanamoment.net/drug-testing-industry-and-pharma-company-ask-federal-appeals-court-to-block-marijuana-rescheduling/